世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

アジア太平洋地域のGERD(胃食道逆流症)治療薬・機器市場予測 2019-2027年

ASIA PACIFIC GERD DRUGS AND DEVICES MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2018年11月US$1,250
シングルユーザライセンス(印刷不可PDF)
85

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートはアジア太平洋地域のGERD(胃食道逆流症)治療薬・機器市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The APAC region market for GERD drugs and devices account growth of 1.52% CAGR through the forecasted years of 2019-2027. This region includes Japan, China, India, South Korea, Australia and the Rest of Asia.

MARKET INSIGHTS

The largest revenue contributor to the APAC market for GERD drugs and devices are Japan, China and India because of driving factors like availability of fewer approved drugs to treat GERD and increasing awareness about GERD among the patients that are pushing the growth of this market.

COMPETITIVE INSIGHTS

Some of the companies that provides additional revenue of the global GERG drugs and devices market are Abbott Laboratories, AstraZeneca, Ausch Health (Formerly Valeant Pharmaceuticals International, Inc.), Boston Scientific Corporation, Cempra Inc. (Merged with Melinta), Daewoong Co. Ltd., Eisai Inc., Glaxosmithkline, Ironwood Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer, Inc., RaQualia Pharma Inc. and Takeda Pharmaceuticals Company Limited.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. ANTACIDS DRUG CLASS HOLDS THE LARGEST MARKET SHARE
3.2.2. BRAVO SYSTEM DEVICES ARE WIDELY USED
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. GROWING TREND OF SELF-MEDICATION
4.2.2. INCREASING AWARENESS ABOUT GERD
4.2.3. INCREASING OCCURRENCE OF GERD DISORDERS
4.2.4. CHANGES IN LIFESTYLE
4.3. MARKET RESTRAINTS
4.3.1. PATENT EXPIRY
4.3.2. ADVERSE EFFECT OF PROTON PUMP INHIBITORS AND OTHER DRUGS
4.3.3. PROTON PUMP INHIBITOR RESISTANCE
4.4. MARKET OPPORTUNITIES
4.4.1. INCREASED PRACTICE OF GENERICS AND OTC DRUGS
4.4.2. COST-EFFECTIVE OTC DRUGS
4.4.3. OVERUSE OF MEDICATION AND DIETARY SUPPLEMENTS
4.5. MARKET CHALLENGES
4.5.1. USE OF COMPLEMENTARY AND ALTERNATIVE TREATMENTS
4.5.2. PROBABILITY OF BUYING COUNTERFEIT DRUGS
4.6. MARKET BY DRUGS DOSAGE FORM
4.7. MARKET BY ROUTE OF ADMINISTRATION OF DRUGS
5. MARKET BY DRUGS AND DEVICES
5.1. DRUG CLASS
5.1.1. ANTACIDS
5.1.2. H2 RECEPTOR BLOCKERS
5.1.3. PROTON PUMP INHIBITORS (PPI)
5.1.4. PRO-KINETIC AGENTS
5.2. DEVICES
5.2.1. DIGITRAPPER
5.2.2. BRAVO SYSTEM
5.2.3. STRETTA
5.2.4. LINX REFLUX MANAGEMENT SYSTEM
5.2.5. MUSE (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM
5.2.6. OTHER DEVICES
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE
6.1.3. BARGAINING POWER OF SUPPLIERS
6.1.4. BARGAINING POWER OF BUYERS
6.1.5. THREAT OF COMPETITIVE RIVALRY
6.2. PIPELINE DRUGS
6.3. REGULATORY FRAMEWORK
6.4. PATENT ANALYSIS
6.5. OPPORTUNITY MATRIX
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA PACIFIC
7.1.1. JAPAN
7.1.2. CHINA
7.1.3. INDIA
7.1.4. AUSTRALIA
7.1.5. SOUTH KOREA
7.1.6. REST OF ASIA PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. COMPANY PROFILES
8.2.1. ABBOTT LABORATORIES.
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCT PORTFOLIO
8.2.1.3. SCOT ANALYSIS
8.2.1.4. STRATEGIC INITIATIVES
8.2.2. ASTRAZENECA
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCT PORTFOLIO
8.2.2.3. SCOT ANALYSIS
8.2.2.4. STRATEGIC INITIATIVES
8.2.3. BAUSCH HEALTH (FORMERLY VALEANT PHARMACEUTICALS INTERNATIONAL, INC.)
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCT PORTFOLIO
8.2.3.3. SCOT ANALYSIS
8.2.3.4. STRATEGIC INITIATIVES
8.2.4. BOSTON SCIENTIFIC CORPORATION
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCT PORTFOLIO
8.2.4.3. SCOT ANALYSIS
8.2.4.4. STRATEGIC INITIATIVES
8.2.5. CEMPRA INC. (MERGED WITH MELINTA)
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCT PORTFOLIO
8.2.5.3. SCOT ANALYSIS
8.2.5.4. STRATEGIC INITIATIVES
8.2.6. DAEWOONG CO. LTD.
8.2.6.1. COMPANY PROFILES
8.2.6.2. PRODUCT PORTFOLIO
8.2.6.3. STRATEGIC INITIATIVES
8.2.7. EISAI INC
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCT PORTFOLIO
8.2.7.3. SCOT ANALYSIS
8.2.7.4. STRATEGIC INITIATIVES
8.2.8. GLAXOSMITHKLINE
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCT PORTFOLIO
8.2.8.3. SCOT ANALYSIS
8.2.8.4. STRATEGIC INITIATIVES
8.2.9. IRONWOOD PHARMACEUTICALS, INC.
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCT PORTFOLIO
8.2.9.3. SCOT ANALYSIS
8.2.9.4. STRATEGIC INITIATIVES
8.2.10. JOHNSON & JOHNSON
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCT PORTFOLIO
8.2.10.3. SCOT ANALYSIS
8.2.10.4. STRATEGIC INITIATIVES
8.2.11. MERCK & CO., INC.
8.2.11.1. COMPANY PROFILES
8.2.11.2. PRODUCT PORTFOLIO
8.2.11.3. SCOT ANALYSIS
8.2.11.4. STRATEGIC INITIATIVES
8.2.12. NOVARTIS
8.2.12.1. COMPANY OVERVIEW
8.2.12.2. PRODUCT PORTFOLIO
8.2.12.3. SCOT ANALYSIS
8.2.12.4. STRATEGIC INITIATIVES
8.2.13. PFIZER, INC.
8.2.13.1. COMPANY PROFILES
8.2.13.2. PRODUCT PORTFOLIO
8.2.13.3. SCOT ANALYSIS
8.2.13.4. STRATEGIC INITIATIVES
8.2.14. RAQUAL IA PHARMA INC.
8.2.14.1. COMPANY OVERVIEW
8.2.14.2. PRODUCT PORTFOLIO
8.2.14.3. STRATEGIC INITIATIVES
8.2.15. TAKEDA PHARMACEUTICALS COMPANY LIMITED
8.2.15.1. COMPANY OVERVIEW
8.2.15.2. PRODUCT PORTFOLIO
8.2.15.3. SCOT ANALYSIS
8.2.15.4. STRATEGIC INITIATIVES



LIST OF TABLES
TABLE 1 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC DRUG CLASS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC DRUG CLASS MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC ANTACIDS MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC H2 RECEPTOR BLOCKERS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC H2 RECEPTOR BLOCKERS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC PROTON PUMP INHIBITORS (PPI) MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC PROTON PUMP INHIBITORS (PPI) MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC PRO-KINETIC AGENTS MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC DEVICES MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC DIGITRAPPER MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC BRAVO SYSTEM MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC STRETTA (MEDERITHERAPEUTICS) MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC LINX? REFLUX MANAGEMENT SYSTEM (TORAX MEDICAL) MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC MUSE? (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC OTHER DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)













LIST OF FIGURES
FIGURE 1 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET SHARE BY DRUGS AND DEVICES 2017 & 2027 (%)
FIGURE 3 PORTER’S FIVE FORCE MODEL
FIGURE 4 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 5 JAPAN GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 6 CHINA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 7 INDIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 8 AUSTRALIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 9 SOUTH KOREA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 10 REST OF ASIA PACIFIC GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 11 GERD PPIS DRUGS PROVIDER COMPANY MARKET SHARE 2017 (%)


List of Tables

LIST OF TABLES
TABLE 1 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC DRUG CLASS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC DRUG CLASS MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC ANTACIDS MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC H2 RECEPTOR BLOCKERS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC H2 RECEPTOR BLOCKERS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC PROTON PUMP INHIBITORS (PPI) MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC PROTON PUMP INHIBITORS (PPI) MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC PRO-KINETIC AGENTS MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC DEVICES MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC DIGITRAPPER MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC BRAVO SYSTEM MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC STRETTA (MEDERITHERAPEUTICS) MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC LINX? REFLUX MANAGEMENT SYSTEM (TORAX MEDICAL) MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC MUSE? (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC OTHER DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

LIST OF FIGURES
FIGURE 1 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET SHARE BY DRUGS AND DEVICES 2017 & 2027 (%)
FIGURE 3 PORTER’S FIVE FORCE MODEL
FIGURE 4 ASIA PACIFIC GERD DRUGS AND DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 5 JAPAN GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 6 CHINA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 7 INDIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 8 AUSTRALIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 9 SOUTH KOREA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 10 REST OF ASIA PACIFIC GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 11 GERD PPIS DRUGS PROVIDER COMPANY MARKET SHARE 2017 (%)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る